Featured Article: Interactions of surface-expressed TLR-4 and endosomal TLR-9 accelerate lupus progression in anti-dsDNA antibody transgenic mice

Experimental Biology and Medicine

Volumn 239, Issue 6, 2014, Pages 715-723

  Lee, Tai Ping ^a   Huang, Jason C ^a   Liu, Chi Jui ^a   Chen, Hsiu Jung ^a   Chen, Yih Horng ^a   Tsai, Yi Ting ^a   Yang, Winnie ^b   Sun, Kuang Hui ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

anti double stranded DNA autoantibody; CpG oligodeoxynucleotide; lipopolysaccharides; Systemic lupus erythematosus; Toll like receptors

Indexed keywords

ANTINUCLEAR ANTIBODY; CPG ODN 1826; CPG ODN 2216; CPG OLIGODEOXYNUCLEOTIDE; DOUBLE STRANDED DNA ANTIBODY; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; OLIGODEOXYRIBONUCLEOTIDE; TLR4 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; IMMUNE COMPLEX DEPOSITION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN URINE LEVEL; PROTEINURIA; SOUTHERN BLOTTING; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; UREA NITROGEN BLOOD LEVEL; AGONISTS; ANIMAL; ENDOSOME; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ENDOSOMES; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, TRANSGENIC; OLIGODEOXYRIBONUCLEOTIDES; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

EID: 84903374035     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214525299     Document Type: Article

References (41)

1. Rahman A,Isenberg DA.Systemic lupus erythematosus.N Engl J Med. 2008;358:929-929.
2. Eroglu GE,Kohler PF.Familial systemic lupus erythematosus: The role of genetic and environmental factors.Ann Rheum Dis. 2002;61:29-29.
3. Bosch X,Guilabert A,Pallares L,Cerveral R,Ramos-Casals M,Bove A,Ingelmo M,Font J.Infections in systemic lupus erythematosus: A prospective and controlled study of 110 patients.Lupus. 2006;15:584-584.
4. Gladman DD,Hussain F,Ibanez D,Urowitz MB.The nature and outcome of infection in systemic lupus erythematosus.Lupus. 2002;11:234-234.
5. Hurst J,von LP.Toll-like receptors and autoimmunity.Autoimmun Rev. 2008;7:204-204.
6. Anders HJ,Schlondorff D.Toll-like receptors: Emerging concepts in kidney disease.Curr Opin Nephrol Hypertens. 2007;16:177-177.
7. Liu B,Yang Y,Dai J,Medzhitov R,Freudenberg MA,Zhang PL,Li Z.TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease.J Immunol. 2006;177:6880-6880.
8. Lee TP,Tang SJ,Wu MF,Song YC,Yu CL,Sun KH.Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes.J Autoimmun. 2010;35:358-358.
9. Christensen SR,Kashgarian M,Alexopoulou L,Flavell RA,Akira S,Shlomchik MJ.Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.J Exp Med. 2005;202:321.-321.
10. Summers SA,Hoi A,Steinmetz OM,O'Sullivan KM,Ooi JD,Odobasic D,Akira S,Kitching AR,Holdsworth SR.TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.J Autoimmun. 2010;35:291-291.
11. Wu X,Peng SL.Toll-like receptor 9 signaling protects against murine lupus.Arthritis Rheum. 2006;54:336-336.
12. Christensen SR,Shupe J,Nickerson K,Kashgarian M,Flavell RA,Shlomchik MJ.Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.Immunity. 2006;25:417-417.
13. Sun KH,Yu CL,Tang SJ,Sun GH.Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis.Immunology. 2000;99:352-352.
14. Song YC,Sun GH,Lee TP,Huang JC,Yu CL,Chen CH,Tang SJ,Sun KH.Arginines in the CDR of anti-dsDNA autoantibodies facilitate cell internalization via electrostatic interactions.Eur J Immunol. 2008;38:3178-3178.
15. Song YC,Tang SJ,Lee TP,Hung WC,Lin SC,Tsai CY,Ng WV,Wu MF,Sun KH.Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.Arthritis Rheum. 2010;62:2401-2401.
16. Sun KH,Tang SJ,Wang YS,Lin WJ,You RI.Autoantibodies to dsDNA cross-react with the arginine-glycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2.Rheumatology (Oxford). 2003;42:154-154.
17. Luan HY,Tang SJ,Yang W,Tsai CY,Sun GH,Sun KH.Monoclonal anti-double-stranded DNA antibodies cross-react with phosphoglycerate kinase 1 and inhibit the expression and production of IL-2 in activated Jurkat T cell line.Clin Immunol. 2006;120:326-326.
18. Waters ST,McDuffie M,Bagavant H,Deshmukh US,Gaskin F,Jiang C,Tung KS,Fu SM.Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis.J Exp Med. 2004;199:255-255.
19. Yung S,Chan TM.Anti-DNA antibodies in the pathogenesis of lupus nephritis-the emerging mechanisms.Autoimmun Rev. 2008;7:317-317.
20. van Bavel CC,Fenton KA,Rekvig OP,van der Vlag J,Berden JH.Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus.Arthritis Rheum. 2008;58:1892-1892.
21. Rekvig OP,Nossent JC.Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: A time for new paradigms?.Arthritis Rheum. 2003;48:300-300.
22. Chun HY,Chung JW,Kim HA,Yun JM,Jeon JY,Ye YM,Kim SH,Park HS,Suh CH.Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.J Clin Immunol. 2007;27:461-461.
23. Beebe AM,Cua DJ,de Waal MR.The role of interleukin-10 in autoimmune disease: Systemic lupus erythematosus (SLE) and multiple sclerosis (MS).Cytokine Growth Factor Rev. 2002;13:403-403.
24. Llorente L,Richaud-Patin Y,Garcia-Padilla C,Claret E,Jakez-Ocampo J,Cardiel MH,Alcocer-Varela J,Grangeot-Keros L,Alarcon-Segovia D,Wijdenes J,Galanaud P,Emilie D.Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus.Arthritis Rheum. 2000;43:1790-1790.
25. Ishida H,Muchamuel T,Sakaguchi S,Andrade S,Menon S,Howard M.Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.J Exp Med. 1994;179:305-305.
26. Liu TF,Jones BM.Impaired production of IL-12 in system lupus erythematosus. II: IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE.Cytokine. 1998;10:148-148.
27. Yin Z,Bahtiyar G,Zhang N,Liu L,Zhu P,Robert ME,McNiff J,Madaio MP,Craft J.IL-10 regulates murine lupus.J Immunol. 2002;169:2148-2148.
28. Blenman KR,Duan B,Xu Z,Wan S,Atkinson MA,Flotte TR,Croker BP,Morel L.IL-10 regulation of lupus in the NZM2410 murine model.Lab Invest. 2006;86:1136-1136.
29. Su DL,Lu ZM,Shen MN,Li X,Sun LY.Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE.J Biomed Biotechnol. 2012;2012:347141-347141.
30. Jacob N,Guo S,Mathian A,Koss MN,Gindea S,Putterman C,Jacob CO,Stohl W.B Cell and BAFF dependence of IFN-alpha-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.J Immunol. 2011;186:4984-4984.
31. Baccala R,Hoebe K,Kono DH,Beutler B,Theofilopoulos AN.TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.Nat Med. 2007;13:543-543.
32. Thibault DL,Graham KL,Lee LY,Balboni I,Hertzog PJ,Utz PJ.Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.Arthritis Res Ther. 2009;11:R112-R112.
33. He B,Qiao X,Cerutti A.CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.J Immunol. 2004;173:4479-4479.
34. Savarese E, Steinberg C, Pawar RD, Reindl W, Akira S, Anders HJ, Krug A. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum 2008;58:1107.
35. Santiago-Raber ML,Baudino L,Izui S.Emerging roles of TLR7 and TLR9 in murine SLE.J Autoimmun. 2009;33:231-231.
36. Christensen SR,Kashgarian M,Alexopoulou L,Flavell RA,Akira S,Shlomchik MJ.Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.J Exp Med. 2005;202:321-321.
37. Pawar RD,Patole PS,Ellwart A,Lech M,Segerer S,Schlondorff D,Anders HJ.Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis.J Am Soc Nephrol. 2006;17:3365-3365.
38. Ehlers M,Ravetch JV.Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance.Trends Immunol. 2007;28:74-74.
39. Papadimitraki ED,Tzardi M,Bertsias G,Sotsiou E,Boumpas DT.Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: Implications for the amplification of the inflammatory response.Lupus. 2009;18:831-831.
40. Chen M,Zhang W,Xu W,Zhang F,Xiong S.Blockade of TLR9 signaling in B cells impaired anti-dsDNA antibody production in mice induced by activated syngenic lymphocyte-derived DNA immunization.Mol Immunol. 2011;48:1532-1532.
41. De Nardo D,De Nardo CM,Nguyen T,Hamilton JA,Scholz GM.Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages.J Immunol. 2009;183:8110-8110.